News

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
STAT9h
U.S. health officials inject new uncertainty into approval process for Covid boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
FDA appears to be slow-walking vaccine approvals
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
BioPharma Dive5h
Novavax says vaccine application still ‘approvable,’ despite FDA delay
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Infectious Disease Advisor9h
Novavax COVID-19 Vaccine Moves Closer to Full FDA Approval
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
pharmaphorum22h
Teva's long-acting schizophrenia drug rejected by FDA
Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined ... with ivermectin to see if it can treat COVID-19. Even if approved, TV-46000 could ...
pharmaphorum22h
US eyes link between Pfizer bivalent COVID jab and stroke
The vaccine was approved by the FDA for people aged 12 and over in August ... as they are more at risk for serious complications from COVID-19 infections. The stroke signal has not been identified ...